Fresenius Medical Care AG & Co. KGaA (FMS) has a consensus analyst rating of Hold, based on 18 analysts covering the stock. Of those, 5 recommend buying, 12 recommend holding, and 1 recommend selling.
The analyst consensus price target for FMS is $28.00, representing a +20.6% upside from the current price of $23.21. Price targets range from a low of $28.00 to a high of $28.00.
